Study design of the InTakeCare trial: a digital health solution to monitor and improve medication adherence in hypertensive patients

Read full text Summarise with VIRAT
Authors: Emanuele Tauro, Alessandra Gorini, Martina Vigorè, Lucia Zanotti, Alessandro Croce, Martino Francesco Pengo, Davide Soranna, Antonella Zambon, Gianfranco Parati, Enrico Gianluca Caiani, Grzegorz Bilo
Cited by: 0
References: 44

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Aims: The InTakeCare Trial aims to develop, implement, and clinically validate a novel digital health solution (DHS) to improve medication adherence (MA) in patients with arterial hypertension. This initiative responds to the global issue of poor MA to long-term pharmacological treatments, compromising patient outcomes and increasing healthcare costs. Methods and results: This study is structured as a multidisciplinary, single-centre, randomized, open, blinded-endpoint clinical trial. In the preliminary phase, focus groups and a survey are conducted to develop patient personas and fictional archetypes that represent real people in the development of interventions, informing the personalization of a mobile application for patients and a web dashboard for physicians. The developed DHS is designed to deliver tailored reminders, health messages, and real-time monitoring of MA. After a pilot usability phase, 206 hypertensive patients will be randomized to standard care or active intervention for a 3-month period, followed by a 2-month observational phase to assess the persistence of intervention effects on adherence. MA is measured via direct (e.g. plasma drug levels) and indirect (e.g. self-reports) methods, alongside ambulatory blood pressure monitoring and behavioural engagement scales. Conclusion: This study offers a novel, theory-informed framework for the design of personalized DHS in chronic disease management. Leveraging user-centred design and machine learning-driven persona classification, InTakeCare introduces a scalable, evidence-based solution that addresses individual variability in adherence behaviours. The trial's findings are expected to generate insights into the efficacy, usability, and acceptability of personalized DHS in routine clinical practice, providing a replicable model for future DHS in other chronic conditions.

Fields of Study & Subjects

Medication Adherence and Compliance Mobile Health and mHealth Applications Health Technology Consumer Behavior

Publication details

Journal / source
European Heart Journal - Digital Health
Volume
7
Issue
4
Pages
ztag051–ztag051
Publication date
27 March 2026
Language
EN